Dermapharm Holding SE (ETR:DMP)
Germany flag Germany · Delayed Price · Currency is EUR
48.75
-0.35 (-0.71%)
May 29, 2026, 5:35 PM CET

Dermapharm Holding SE Ratios and Metrics

Millions EUR. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
May '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
2,4152,1192,0942,2802,0204,808
Market Cap Growth
27.44%1.16%-8.13%12.85%-57.98%56.78%
Enterprise Value
3,2252,9803,0073,2582,4935,294
Last Close Price
48.7539.3537.8940.2534.8879.30
PE Ratio
18.2016.0018.4136.5515.0522.94
Forward PE
17.7315.9416.6617.4410.6122.27
PS Ratio
2.041.801.751.981.945.01
PB Ratio
3.293.073.444.183.799.62
P/TBV Ratio
----41.96310.95
P/FCF Ratio
10.0311.3312.8412.828.1025.42
P/OCF Ratio
8.489.2510.4010.397.0019.20
EV/Sales Ratio
2.732.532.522.832.405.51
EV/EBITDA Ratio
11.4011.2611.9914.798.2416.95
EV/EBIT Ratio
13.0612.5913.5416.878.8217.89
EV/FCF Ratio
13.3915.9318.4318.319.9927.98
Debt / Equity Ratio
1.411.531.632.010.971.16
Debt / EBITDA Ratio
3.733.893.854.831.691.83
Debt / FCF Ratio
4.325.666.076.152.073.07
Net Debt / Equity Ratio
1.111.241.431.710.680.84
Net Debt / EBITDA Ratio
3.003.223.464.241.201.34
Net Debt / FCF Ratio
3.384.565.325.251.462.21
Asset Turnover
0.540.550.560.640.740.73
Inventory Turnover
1.151.231.341.551.571.56
Quick Ratio
0.930.950.720.751.181.61
Current Ratio
2.002.051.821.602.453.34
Return on Equity (ROE)
20.80%20.22%19.38%11.24%25.69%50.68%
Return on Assets (ROA)
6.93%6.93%6.55%6.76%12.53%14.06%
Return on Invested Capital (ROIC)
11.52%11.21%9.76%9.29%19.12%24.46%
Return on Capital Employed (ROCE)
12.90%12.80%12.70%10.90%23.70%23.60%
Earnings Yield
5.97%6.25%5.43%2.74%6.64%4.36%
FCF Yield
9.97%8.83%7.79%7.80%12.35%3.93%
Dividend Yield
1.79%2.24%2.38%2.19%3.01%2.74%
Payout Ratio
33.60%36.59%41.64%90.64%87.04%22.61%
Total Shareholder Return
1.84%2.24%2.38%2.19%3.01%2.74%
Source: S&P Global Market Intelligence. Standard template. Financial Sources.